PHK
JAZZ icon

Point72 Hong Kong’s Jazz Pharmaceuticals JAZZ Stock Holding History

Point72 Hong Kong’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-11,350
Closed -$1.41M – 595
2025
Q1 		$1.41M Buy
+11,350
New +$1.48M 0.09% 174
2022
Q2 		– Sell
-6,539
Closed -$1.02M – 2166
2022
Q1 		$1.02M Buy
+6,539
New +$949K 0.03% 505
2021
Q4 		– Sell
-15,047
Closed -$1.96M – 2129
2021
Q3 		$1.96M Buy
+15,047
New +$2.27M 0.06% 477
2021
Q1 		– Sell
-614
Closed -$101K – 2008
2020
Q4 		$101K Buy
+614
New +$91.5K ﹤0.01% 1068
2020
Q2 		– Sell
-1,310
Closed -$131K – 1280
2020
Q1 		$131K Sell
1,310
-297
-18% -$38.4K 0.06% 153
2019
Q4 		$240K Buy
+1,607
New +$219K 0.06% 289
2018
Q3 		– Sell
-13
Closed -$2K – 1036
2018
Q2 		$2K Buy
+13
New +$2.13K ﹤0.01% 778
2016
Q2 		– Sell
-4,494
Closed -$587K – 584
2016
Q1 		$587K Buy
4,494
+4,394
+4,394% +$547K 1.14% 20
2015
Q4 		$14K Sell
100
-594
-86% -$82.3K 0.05% 236
2015
Q3 		$92K Buy
+694
New +$119K 0.14% 56
2014
Q4 		– Sell
-93
Closed -$15K – 579
2014
Q3 		$15K Buy
+93
New +$14.3K 0.01% 232

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Point72 Hong Kong's JAZZ Position: Q2 2025 in Review

Point72 Hong Kong sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2025, closing a stake of 11,350 shares — an estimated $1.41M sold.

Point72 Hong Kong first reported a position in JAZZ in Q3 2014 and held it in 11 quarters. The position peaked at $1.96M in Q3 2021. 501 funds tracked by Wall St. Rank hold JAZZ as of Q2 2025.

  • Point72 Hong Kong reported no remaining Jazz Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Point72 Hong Kong sold 11,350 Jazz Pharmaceuticals shares in Q2 2025, an estimated $1.41M.
  • Point72 Hong Kong first reported a position in Jazz Pharmaceuticals in Q3 2014 and held it in 11 quarters.
  • Point72 Hong Kong's Jazz Pharmaceuticals position peaked at $1.96M in Q3 2021.
  • 501 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2025.

Based on Point72 Hong Kong's 13F filing for Q2 2025, filed 14 Aug 2025.